期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血清癌胚抗原检测在风湿性疾病中的临床意义 被引量：2

下载PDF
导出
摘要 目的探讨在风湿性疾病中检测血清癌胚抗原（CEA）的临床意义.方法将我院收治的风湿性疾病患者 40 例选为研究对象,检测 CEA分析靶器官损伤、感染情况,行针对性治疗,比较治疗前后检测指标水平.结果40例患者中60.0%肺部受累,75.0%关节肿痛,15.0%肾脏受累,15.0%血液系统受累,10.0%心肌损害;25.0%合并肺内感染,治疗后9例 CEA水平恢复正常;82.5%经治疗后复查CEA,结果从（6.72±1.75）ng/ml 降至（4.57±1.05）ng/ml,对比P〈0.05,且CRP、ESR与治疗前相比也明显下降（P〈0.05）.结论在风湿性疾病中检测CEA临床价值高,便于辨别有无癌症,值得推广.
作者 苏丽芳 吴芬芝 孔宏伟
机构地区 浙江省衢州市人民医院
出处 《湖南中医药大学学报》 CAS 2016年第A01期135-136,共2页 Journal of Hunan University of Chinese Medicine
关键词 血清癌胚抗原 风湿性疾病 临床意义
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献3

二级参考文献43

  • 1Rajeswaran A,Trojan A,Burnand B,et al.Efficacy and side effects of cisplatin and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma:a systematic review of randomized controlled trials[J].Lung Cancer,2008,59(1):1-11.
  • 2Govindan R,Morgensztern D,Kommor MD,et al.Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer[J].J Thorac Oncol,2011,6(4):790-795.
  • 3Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].N Engl J Med,2002,346:92-98.
  • 4Trillet-Lenoir V,Freyer G,Kaemmerlen P,et al.Assessment of tumour response to chemotherapy for metastatic colorectal cancer:accuracy of the RECIST criteria[J].Br J Radiol,2002,75(899):903-908.
  • 5Chou WC,Huang SF,Yeh KY,et al.Different responses to gefitinib in lung adenocarcinoma coexpressing mutant and wild-type epidermal growth factor receptor genes[J].Jpn J Clin Oncol,2006,36:523-526.
  • 6Suzuki C,Jacobsson H,Hatschek T,et al.Radiologic measurements of tumor response to treatment:practical approaches and limitations[J].Radiographics,2008,28(2):329-44.
  • 7Nisman B,Biran H,Heching N,et al.Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer:association of marker changes after two chemotherapy cycles with different measures of clinical response and survival[J].Br J Cancer,2008,98(1):77-79.
  • 8Armstrong AJ,Garrett-Mayer E,De Wit R,et al.Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer[J].Clin Cancer Res,2010,16(1):203-211.
  • 9Hammad N,Heilbrun LK,Philip PA,et al.CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy[J].Asia Pac J Clin Oncol,2010,6(2):98-105.
  • 10Zaeska M,Szturmowicz M,Zych J,et al.The significance of the serum tumour markers as a prognostic and predictor factors in nonsmall cell lung cancer patients[J].Pneumonol Alergol Pol,2005,73(3):270-276.

共引文献28

同被引文献6

引证文献2

二级引证文献9

湖南中医药大学学报
2016年 第A01期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部